Prudential Financial Inc. Has $19.07 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Prudential Financial Inc. lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 243,966 shares of the company’s stock after selling 32,006 shares during the quarter. Prudential Financial Inc. owned 0.05% of GE HealthCare Technologies worth $19,073,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of GEHC. Cherry Creek Investment Advisors Inc. grew its position in shares of GE HealthCare Technologies by 0.3% during the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock worth $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky grew its position in GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock worth $158,000 after buying an additional 114 shares in the last quarter. Tandem Capital Management Corp ADV increased its stake in GE HealthCare Technologies by 0.4% during the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after acquiring an additional 118 shares during the period. Arcus Capital Partners LLC raised its holdings in GE HealthCare Technologies by 3.0% in the 4th quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company’s stock valued at $322,000 after acquiring an additional 119 shares in the last quarter. Finally, Custom Index Systems LLC lifted its position in shares of GE HealthCare Technologies by 4.4% during the 4th quarter. Custom Index Systems LLC now owns 2,843 shares of the company’s stock valued at $222,000 after acquiring an additional 120 shares during the period. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently commented on GEHC. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Citigroup boosted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Trading Down 1.8 %

Shares of GEHC stock opened at $81.00 on Thursday. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The stock’s fifty day simple moving average is $86.86 and its 200 day simple moving average is $85.93. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $37.04 billion, a P/E ratio of 18.71, a P/E/G ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.